Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × NIH × Iloprost × Clear all

Phase

Status

Withdrawn 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 1

Interventions

Cyclophosphamide 160 Radiotherapy 134 Bevacizumab 117 Cisplatin 109 Paclitaxel 106 Carboplatin 106 Doxorubicin 96 Fluorouracil 95 Filgrastim 89 Etoposide 88 Vincristine 79 Leucovorin 73 Gemcitabine 72 aldesleukin 69 Bortezomib 69 Cytarabine 62 fludarabine phosphate 61 Irinotecan 61 Docetaxel 56 Taxes 55 Sorafenib 55 Oxaliplatin 54 Sirolimus 53 Erlotinib Hydrochloride 52 temsirolimus 51 sargramostim 50 Vorinostat 49 Rituximab 49 Methotrexate 46 Magnetic Resonance Spectroscopy 45

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02237183 2023-11-28

Iloprost in Preventing Lung Cancer in Former Smokers

National Cancer Institute (NCI)

Phase 1 Completed

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡